Advertisement
Advertisement

ABSI

ABSI logo

Absci Corporation Common Stock

3.00
USD
Sponsored
-0.03
-1.16%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

2.98

-0.01
-0.33%

ABSI Earnings Reports

Positive Surprise Ratio

ABSI beat 3 of 18 last estimates.

17%

Next Report

Date of Next Report
Mar 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.12M
/
-$0.19
Implied change from Q3 25 (Revenue/ EPS)
+196.83%
/
-5.00%
Implied change from Q4 24 (Revenue/ EPS)
+68.72%
/
-24.00%

Absci Corporation Common Stock earnings per share and revenue

On Nov 12, 2025, ABSI reported earnings of -0.20 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 7.36% surprise. Revenue reached 378.00 thousand, compared to an expected 1.68 million, with a -77.45% difference. The market reacted with a -22.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 1.12 million USD, implying an decrease of -5.00% EPS, and increase of 196.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Absci Corporation Common Stock reported EPS of -$0.20, beating estimates by 7.36%, and revenue of $378.00K, -77.45% below expectations.
The stock price moved down -22.35%, changed from $3.40 before the earnings release to $2.64 the day after.
The next earning report is scheduled for Mar 16, 2026.
Based on 11 analysts, Absci Corporation Common Stock is expected to report EPS of -$0.19 and revenue of $1.12M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement